Skip to content

Coronavirus (COVID-19) deaths, %%COUNTRY%% data


Source: World Health Organization

Loading...

Trends in hospitalizations, %%COUNTRY%%

New hospitalizations reported to WHO (weekly)

%%COUNTRY%%, July 2023 - present


Source: World Health Organization

Data may include corrections and be incomplete for the latest week

New hospitalizations reported to WHO (28 days)

%%COUNTRY%%, January 2020 - present


Source: World Health Organization

ICU admissions, %%COUNTRY%%

Coronavirus (COVID-19) deaths, %%COUNTRY%% data


Source: World Health Organization

Data may include corrections and be incomplete for the latest week
Loading...

Trends in ICU admissions, %%COUNTRY%%

New ICU admissions reported to WHO (weekly)

%%COUNTRY%%, July 2023 - present


Source: World Health Organization

Data may include corrections and be incomplete for the latest week

New ICU admissions reported to WHO (28 days)

%%COUNTRY%%, January 2020 - present


Source: World Health Organization


 


 


 

Coronavirus (COVID-19) deaths, %%COUNTRY%% data

Severity Rate per 1000 Hospitalizations, %%COUNTRY%%

Coronavirus (COVID-19) deaths, %%COUNTRY%% data

Rate of ICU admissions per 1000 hospitalizations reported to WHO (28 days)

%%COUNTRY%%


Source: World Health Organization

Data may include corrections and be incomplete for the latest week

Rate of deaths per 1000 hospitalizations reported to WHO (28 days)

%%COUNTRY%%


Source: World Health Organization



Metadata

Glossary and definitions

HospitalizationsA COVID-19 associated hospitalization is defined as admission as an inpatient for a length of over 12 hours of time, or overnight for the reasons directly related to COVID-19.
ICUIntensive care unit
ICU admissionsA COVID-19 associated ICU admission is defining admission of critically ill patient directly related to COVID-19 requiring an organized system providing care which offers intensive and specialized medical and nursing care, enhanced monitoring, and multiple methods of physiological organ support to sustain life during periods of life-threatening organ system failure.

Given the wide range of health systems and case management worldwide, ICU admission can include, beyond strictly counting admissions to intensive care units, patients with COVID-19 placed on advanced respiratory support measures such as mechanical ventilation or extracorporeal membrane oxygenation (ECMO) in other parts of the hospital.
Death due to COVID-19

A COVID-19 death is defined for surveillance purposes as a death resulting from a clinically compatible illness in a probable or confirmed COVID-19 case unless there is a clear alternative cause of death that cannot be related to COVID-19 disease (e.g. trauma). There should be no period of complete recovery between illness and death

Last 7 days‘Last 7 days’ refers to the most recent complete epidemiological week (commonly referred to as an 'epi week').
Last 28 days‘Last 28 days’ refers to the four preceding most recently complete epidemiological weeks.
WHO RegionsThe World Health Organization (WHO) is divided into six regions with regional offices, each responsible for addressing health challenges and promoting public health within its designated geographical area. These regions serve as administrative units that allow the WHO to tailor its efforts to the specific needs, priorities, and health conditions of member countries within each region.
World Bank Income GroupsThe World Bank classifies economies into income groups based on their Gross National Income (GNI) per capita. These annually updated classifications help the World Bank and other organizations analyze and understand global economic trends, allocate resources, and design development policies.

Data sources

 
COVID-19 hospitalization and ICU admission data

Data in this section are combined from the following sources: official reporting to WHO through regional offices via case report forms or weekly aggregate reporting, and taken from official public websites, not officially reported to WHO. WHO Member States select the reporting system they prefer to use, and data from different reporting systems are reconciled (referred to as "detailed surveillance data"). Individual countries, areas, and territories may decline to allow country-level disaggregation.

Counts primarily reflect laboratory-confirmed hospitalizations, based upon WHO definitions, although some departures may exist due to local adaptations. Counts include both domestic and repatriated cases. Case detection, definitions, testing strategies, reporting practices, and lag times (e.g., time to case notification and time to reporting of hospitalizations) differ between countries, territories, and areas. These factors, amongst others, influence the counts presented, with variable under- or overestimation of true counts, and variable delays in reflecting these data at a global level.

Caveats:

  • Completeness for indicators varies between countries, regions, and over time.
  • Detailed surveillance data may reflect different sub-national jurisdictions than those used for cases and deaths data, and thus may not follow a similar pattern.
  • Reporting delays can be observed.
  • Case identification in a country is subject to detection and testing strategies, which vary between countries and over time.
  • Regardless of the definitions provided, these data might include incidental hospitalizations and ICU admissions.
  • Due to varying degrees of information collection and submission, it is recommended to analyze each country/territory independently.
  • Data sources might change over time from universal to sentinel reporting for some indicators in some countries (e.g., new hospitalizations from the United States of America are reported from a hospital network from 20 February 2024). Due to the scarcity of the reporting globally and the importance of sharing the available information publicly, we continue to reflect this data; please be cautious while interpreting sharp decreases in the volume of data compared to previous periods.

All data represent the date of admission as opposed to the date of reporting. Data are reported remotely and refreshed once a week in this report, while data quality control and data cleaning are continuous.

Thus, they may change based on retrospective updates to accurately reflect trends, changes in country case definitions, and/or reporting practices. Significant data errors detected or reported to WHO may be corrected at more frequent intervals.

COVID-19 death data

From the 31 December 2019 to the 21 March 2020, WHO collected the numbers of confirmed COVID-19 cases and deaths through official communications under the International Health Regulations (IHR, 2005), complemented by monitoring the official ministries of health websites and social media accounts. Since 22 March 2020, global data is compiled through WHO region-specific dashboards, and/or aggregate count data reported to WHO headquarters.

WHO COVID-19 Dashboard is updated every Friday for the period of two weeks prior.

Counts primarily reflect laboratory-confirmed cases and deaths, based upon WHO case definitions; although some departures may exist due to local adaptations. Counts include both domestic and repatriated cases. Case detection, definitions, testing strategies, reporting practice, and lag times (e.g. time to case notification, and time to reporting of deaths) differ between countries, territories and areas. These factors, amongst others, influence the counts presented with variable under or overestimation of true case and death counts, and variable delays to reflecting these data at a global level.

All data represent date of reporting as opposed to date of symptom onset. All data are subject to continuous verification and may change based on retrospective updates to accurately reflect trends, changes in country case definitions and/or reporting practices. Significant data errors detected or reported to WHO may be corrected at more frequent intervals.

New case and death counts from the Region of the Americas
Starting from the week commencing on 11 September 2023, the source of the data from the Region of the Americas was switched to the aggregated national surveillances, received through the COVID-19, Influenza, RSV and Other Respiratory Viruses program in the Americas. Data have been included retrospectively since 31 July 2023.

Rates
<0.001 per 100,000 population may be rounded to 0.

Population data

Estimated populations and projections are drawn from:

*Total population for France has been adjusted to account for the following overseas territories (French Guiana, Guadeloupe, Martinique, Mayotte, Réunion, Saint Martin).

Copyright and licensing

Copyright

Attribution 4.0 International (CC BY 4.0)

License

The World Health Organization (“WHO”) encourages public access and use of the data that it collects and publishes on its web site data.who.int. The data are organized in datasets and made available in machine-readable format (“Datasets”). The Datasets have been compiled from data provided by WHO’s Member States under the WHO policy on the use and sharing of data collected by WHO in Member States outside the context of public health emergencies.

Use of the data derived from the Datasets, which may appear in formats such as tables and charts, is also subject to these Terms and Conditions. Datasets may include data describing the Dataset called “Metadata”. If any datasets are credited to a source other than WHO, then those materials are not covered by these Terms and Conditions, and permission should be sought from the source provided. You are responsible for determining if this is the case, and if so, you are responsible for obtaining any necessary permission from the sources indicated. The risk of claims resulting from infringement of any third-party-owned component in the materials rests solely with you.

You may use our application programming interfaces (“APIs”) to facilitate access to the Datasets, whether through a separate web site or through another type of software application. By using the Datasets or any presentations of data derived from them, or by using our APIs in connection with the Datasets, you agree to be bound by these Terms and Conditions, as may be amended from time to time by WHO at its sole discretion.

Unless specifically indicated otherwise, these Datasets are provided to you under a Creative Commons Attribution 4.0 International License (CC BY 4.0), with the additional terms below. The basic terms applicable to the CC BY 4.0 license may be accessed here. By downloading or using the Datasets, you agree to comply with the terms of the CC BY 4.0 license, as well as the following mandatory and binding addition:

Any dispute relating to the interpretation or application of this license shall, unless amicably settled, be subject to conciliation. In the event of failure of the latter, the dispute shall be settled by arbitration. The arbitration shall be conducted in accordance with the modalities to be agreed upon by the parties or, in the absence of agreement, with the UNCITRAL Arbitration Rules. The parties shall accept the arbitral award as final.

Permission typePublicly accessible
Prohibited uses

You shall not attempt to de-anonymise the Datasets or use the Datasets in a manner that falsifies or misrepresents their content.

You shall not, in connection with your use of the Datasets published on data.who.int, state or imply that WHO endorses, or is affiliated with, you, or that WHO endorses your use of data.who.int, or any content, output, or analysis resulting from or related to the data.who.int, or any entity, organization, company, product or services.

Citation

World Health Organization 2023 data.who.int, WHO Coronavirus (COVID-19) dashboard > More resources [Dashboard]. https://data.who.int/dashboards/covid19/more-resources

Disclaimer

WHO reserves the right at any time and from time to time to modify or discontinue, temporarily or permanently, the Datasets, or any means of accessing or utilizing the Datasets with or without prior notice to you.

Maps
The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of WHO concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.

All references to Kosovo should be understood to be in the context of the United Nations Security Council resolution 1244 (1999).

A dispute exists between the Governments of Argentina and the United Kingdom of Great Britain and Northern Ireland concerning sovereignty over the Falkland Islands (Malvinas).

The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by WHO in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.

All reasonable precautions have been taken by WHO to verify the accuracy of the Datasets. However, the Datasets are being provided without warranty of any kind, either expressed or implied. You will be solely responsible for your use of the Datasets. In no event shall WHO be liable for any damages arising from such use.

Regional reclassification for Indonesia: 1 January 2025, Indonesia has been reclassified from the WHO South-East Asia Region to the Western Pacific Region. As a result, data to and including 31 December 2024 will be reported under the South-East Asia Region, while data from 1 January 2025 onward will be reported under the Western Pacific Region for this country up.

For full disclaimers, terms of use and your indemnification of WHO, please visit Terms and Conditions.